VH032-PEG5-C6-Cl

Background Introduction

VH032-PEG5-C6-Cl is a versatile E3 ligase ligand-linker conjugate commonly used in the design and synthesis of PROTACs (Proteolysis Targeting Chimeras). Leveraging the recognized VH032 moiety, which is a potent ligand for the von Hippel-Lindau (VHL) E3 ubiquitin ligase, this conjugate features a PEG5 (polyethylene glycol, five units) spacer and a reactive C6-chloride tail ready for further chemical modification. This optimized composition facilitates robust and modular PROTAC assembly for targeted protein degradation research in chemical biology and drug discovery.

Mechanism

The mechanism of VH032-PEG5-C6-Cl centers on its function as a bifunctional E3 ligase recruiter. The VH032 moiety binds specifically and tightly to the VHL E3 ligase complex. The PEG5 linker imparts flexibility and spatial separation, critical for effective ternary complex formation in PROTACs. The terminal C6-chloride functions as a reactive handle for covalent conjugation to a ligand that binds the target protein of interest. Once incorporated into a PROTAC molecule, VH032-PEG5-C6-Cl facilitates the recruitment of the VHL E3 ligase to the target protein, promoting its ubiquitination and subsequent degradation by the proteasome.

Applications

VH032-PEG5-C6-Cl is broadly utilized in PROTAC research and development. It serves as an essential building block for synthesizing VHL-based PROTACs designed to selectively degrade disease-related proteins. Researchers use this conjugate to craft custom degrader molecules against challenging targets in oncology, neurodegeneration, immunology, and other therapeutic areas. Owing to its modular design, VH032-PEG5-C6-Cl streamlines the rapid generation and optimization of PROTAC libraries, accelerating hit identification and lead optimization in drug discovery pipelines.

• Flexible PEG5 and C6 linker enables optimal spatial arrangement for efficient target protein degradation.
• Chloride-functionalized VH032 ligand ensures high specificity and reliable binding to VHL E3 ligase in PROTAC design.

The E3 Ligase Ligand-Linker Conjugate *VH032-PEG5-C6-Cl* plays a crucial role in PROTACs by facilitating the targeted degradation of proteins through precise molecular interactions. This conjugate combines a bifunctional linker with a potent ligand, optimizing the selection of target protein ligands for effective therapeutic applications.

Linker: The linker in this molecule is a PEG5-C6 construct, providing moderate length and flexibility. Its polyethylene glycol (PEG) component enhances solubility and biocompatibility, while the alkyl chain contributes to its structural stability. This linker is non-cleavable, ensuring sustained activity during protein degradation processes.

Ligand: The ligand is based on the VH032 scaffold, known for its high affinity and specificity towards the VHL E3 ligase. Its structural characteristics include a compact and hydrophobic core, which facilitates efficient binding and enhances the overall efficacy of the PROTAC.

Reactive Site: The chloro group (Cl) serves as the reactive site for coupling with the target protein ligand. This site is suited for nucleophilic substitution reactions, such as SN2, which are ideal for forming stable covalent bonds with the protein ligand.

Recommended Target Protein Ligand: The molecule is compatible with warheads containing nucleophilic groups, such as amines or thiols. These warheads are advantageous due to their ability to form stable covalent bonds, ensuring robust protein-ligand interactions. In experimental studies, such warheads can be employed to target proteins implicated in various diseases, enhancing the specificity and efficiency of the degradation process.